Article Details

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Expected to Post Quarterly Sales of $38.54 Million

Retrieved on: 2020-12-05 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

Jounce Therapeutics, Inc. (NASDAQ:JNCE) Expected to Post Quarterly Sales of $38.54 Million. View article details on hiswai:

Excerpt

Two <b>investment</b> analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a <b>buy</b> rating to the company.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up